Nutrifocus
ActiveSummary
Nutrifocus has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €126,999 and a net result of -€37,428. Equity is growing by ~19.2% per year across the filed fiscal years. Its solvency ranks better than 51% of 527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability0▼-90
Solvency88▼-12
Growth52=
Track record94
Bankruptcy probability, 12 months
1.0%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7,000 at 30 days acceptable
Liquidity ample (current ratio 2.44 against 5.37 in 2024; short-term debt: 37.5% and cash: 82.9% of total assets), and 37.5% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
62.5%
Return on assets
-18.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-05-2026, 73 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
73 d early
2024
14 d late
2023
30 d late
2022
11 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 4 accounts on average 5 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 13 August (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€126,999▼ 44.0%
2024 · €226,871
Total assets
€203,047▼ 25.4%
2024 · €272,339
Net result
-€37,428
2024 · €45,844
Working capital
€109,637▼ 44.9%
2024 · €198,878
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line2022202320242025
Operating result€107,929-€120,936▲ 12.1%€56,956▼ 52.9%-€33,678
Net result€85,039above the sector's middle half-€94,188above the sector's middle half▲ 10.8%€45,844within the sector's middle half▼ 51.3%-€37,428below the sector's middle half
Equity€86,839within the sector's middle half-€181,027within the sector's middle half▲ 108%€226,871within the sector's middle half▲ 25.3%€126,999within the sector's middle half▼ 44.0%
Total assets€117,439below the sector's middle half-€219,012within the sector's middle half▲ 86.5%€272,339within the sector's middle half▲ 24.3%€203,047within the sector's middle half▼ 25.4%
Debt€30,600-€37,985▲ 24.1%€45,468▲ 19.7%€76,048▲ 67.3%
Working capital€65,409within the sector's middle half-€160,952within the sector's middle half▲ 146%€198,878within the sector's middle half▲ 23.6%€109,637within the sector's middle half▼ 44.9%
Solvency73.9%within the sector's middle half-82.7%within the sector's middle half▲ 8.7pp83.3%within the sector's middle half▲ 0.6pp62.5%within the sector's middle half▼ 20.8pp
Current ratio3.14within the sector's middle half-5.24within the sector's middle half▲ 2.105.37within the sector's middle half▲ 0.142.44within the sector's middle half▼ 2.93
Return on assets (ROA)72.4%above the sector's middle half-43.0%above the sector's middle half▼ 29.4pp16.8%within the sector's middle half▼ 26.2pp-18.4%below the sector's middle half▼ 35.3pp
above
within
below
the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €33,678 after €56,956 in 2024, the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €203,047
Fixed assets
€17,362 ▼ 38.0%
Current assets
€185,685 ▼ 24.0%
Equity and liabilities €203,047
Equity
€126,999 ▼ 44.0%
Debt
€76,048 ▲ 67.3%
Debt's share of the balance-sheet total rises from 16.7% to 37.5%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
-€20,577▼
2024 · €65,706
Cash flow
-€24,326▼
2024 · €54,594
Debt to equity
0.60▲
2024 · 0.20
ROE
-29.5%▼
2024 · 20.2%
Interest coverage
-5.04▼
2024 · 127.94
Debt ≤ 1 year
€76,048▲
2024 · €45,468
Income taxes
€141▼
2024 · €12,345
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 3,597 companies that looked in July 2024 the way this one looks now, 2.8% went bankrupt within 24 months and 87% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a loss of 10% of the balance sheet or more
2.8%
went bankrupt
9.2%
stopped otherwise
87%
still going
A further 0.8% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 1.0% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 3,597 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €5,188 | €6,139 | €8,750 | €13,101 | ▲ 49.7% |
| Other operating charges640/8 | €474 | €1,664 | €1,324 | €745 | ▼ 43.8% |
| Non-recurring operating charges66A | - | - | - | €3,045 | - |
| Gross operating margin9900 | €113,592 | €128,739 | €67,030 | -€16,787 | ▼ 125% |
| Operating profit (loss)9901 | €107,929 | €120,936 | €56,956 | -€33,678 | ▼ 159% |
| Financial income75/76B | - | €920 | €1,747 | €475 | ▼ 72.8% |
| Recurring financial income75 | - | €920 | €1,747 | €0 | ▼ 100% |
| Non-recurring financial income76B | - | - | - | €475 | - |
| Financial charges65/66B | €270 | €710 | €514 | €4,084 | ▲ 695% |
| Recurring financial charges65 | €270 | €710 | €514 | €4,084 | ▲ 695% |
| Profit (loss) for the period before taxes9903 | €107,659 | €121,146 | €58,189 | -€37,287 | ▼ 164% |
| Income taxes67/77 | €22,620 | €26,959 | €12,345 | €141 | ▼ 98.9% |
| Profit (loss) for the period9904 | €85,039 | €94,188 | €45,844 | -€37,428 | ▼ 182% |
| Profit (loss) for the period to be appropriated9905 | €85,039 | €94,188 | €45,844 | -€37,428 | ▼ 182% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €117,439 | €219,012 | €272,339 | €203,047 | ▼ 25.4% |
| Fixed assets21/28 | €21,430 | €20,075 | €27,993 | €17,362 | ▼ 38.0% |
| Tangible fixed assets22/27 | €21,430 | €20,075 | €27,993 | €17,362 | ▼ 38.0% |
| Plant, machinery and equipment23 | €2,443 | €2,026 | €2,315 | €2,513 | ▲ 8.6% |
| Furniture and vehicles24 | €416 | €310 | €13,437 | €8,105 | ▼ 39.7% |
| Other tangible fixed assets26 | €18,571 | €17,740 | €12,242 | €6,744 | ▼ 44.9% |
| Current assets29/58 | €96,009 | €198,937 | €244,346 | €185,685 | ▼ 24.0% |
| Amounts receivable within one year40/41 | €6,377 | €6,997 | €5,552 | €17,328 | ▲ 212% |
| Trade receivables40 | €6,377 | €4,800 | €1,600 | €16,018 | ▲ 901% |
| Other amounts receivable41 | - | €2,197 | €3,952 | €1,310 | ▼ 66.9% |
| Cash at bank and in hand54/58 | €89,632 | €191,940 | €238,794 | €168,356 | ▼ 29.5% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €117,439 | €219,012 | €272,339 | €203,047 | ▼ 25.4% |
| Equity10/15 | €86,839 | €181,027 | €226,871 | €126,999 | ▼ 44.0% |
| Contributions10/11 | €1,800 | €1,800 | €1,800 | €1,800 | = |
| Reserves13 | €85,039 | €179,227 | €225,071 | €125,199 | ▼ 44.4% |
| Distributable reserves133 | €85,039 | €179,227 | €225,071 | €125,199 | ▼ 44.4% |
| Profit (loss) carried forward14 | - | - | - | €0 | - |
| Amounts payable17/49 | €30,600 | €37,985 | €45,468 | €76,048 | ▲ 67.3% |
| Amounts payable within one year42/48 | €30,600 | €37,985 | €45,468 | €76,048 | ▲ 67.3% |
| Trade debts44 | €2,058 | €1,062 | €3,685 | €1,716 | ▼ 53.4% |
| Suppliers440/4 | €2,058 | €1,062 | €3,685 | €1,716 | ▼ 53.4% |
| Taxes, remuneration and social security45 | €28,542 | €36,924 | €41,783 | €24,332 | ▼ 41.8% |
| Taxes450/3 | €28,542 | €34,445 | €39,304 | €21,853 | ▼ 44.4% |
| Remuneration and social security454/9 | - | €2,479 | €2,479 | €2,479 | = |
| Other amounts payable47/48 | - | - | - | €50,000 | - |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €85,039 | €94,188 | €45,844 | -€37,428 | ▼ 182% |
| + Depreciation and write-downs630 | €5,188 | €6,139 | €8,750 | €13,101 | ▲ 49.7% |
| Operating cash flow (approximation) | €90,227 | €100,327 | €54,594 | -€24,326 | ▼ 145% |
| Investment in fixed assets (approximation) | - | -€4,784 | -€16,669 | -€2,470 | ▲ 85.2% |
| Change in cash | - | €102,308 | €46,854 | -€70,438 | ▼ 250% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
19-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet -€37,428
Net result drops to -€37,428, the lowest in the series.
14-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 14 days late
2024
31-12
Financial
Equity above €200,000Eq €226,871 ▲25.3%
3 profitable years in a row build equity to €226,871.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-12
Financial
Highest result since 2022net €94,188 ▲10.8%
Operating result €120,936, net result €94,188, both a record.
31-12
Financial
Equity above €150,000Eq €181,027 ▲108%
2 profitable years in a row build equity to €181,027.
11-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 11 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kapellen · 1 establishment unit since 2021
Ground area
2,910 m²
Building footprint
168 m²
Volume, LiDAR
1,126 m³
Parcel 11023I0108/00C009, Flanders · tallest building 16.6 m, ±2 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
Nutrifocus
since 20212.318.956.531
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11023I0108/00C009 | Flanders | 2,910 m² | 1 · 168 m² | 16.6 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2025 · 1 entry · 1,500 EUR awarded · 1,030 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 1,500 EUR | 1,030 EUR |
Similar companies · same sector, comparable size
Nonaki
BE 0778.998.090
Nivelles · Eq €127,287
SciLife Consulting
BE 0732.585.174
Kortenberg · Eq €127,331
CABINET MEDICAL JACQUERIE VANDEPONSEELE
BE 0735.901.782
Floreffe · Eq €125,657
LP ENGINEERING
BE 0754.611.696
Liège · Eq €124,401
BIORES
BE 0452.554.092
Oreye · Eq €123,559
Of 762 companies in sector 72101 we hold annual accounts for 484. 300 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded29-06-2021
Fiscal year end31-12
Activities, NACEBEL 2025
72101Research and development on biotechnology
03220Fishing and aquaculture
E-invoicing
Reachable via Peppol
Peppol ID
0208:0770458231
Also
9925:BE0770458231
Registered
03-10-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.